The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHeadlam Regulatory News (HEAD)

Share Price Information for Headlam (HEAD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 177.00
Bid: 176.00
Ask: 181.50
Change: -3.50 (-1.94%)
Spread: 5.50 (3.125%)
Open: 181.00
High: 181.00
Low: 175.00
Prev. Close: 180.50
HEAD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

5 Aug 2022 07:00

RNS Number : 0027V
Headlam Group PLC
05 August 2022
 

Headlam Group plc

 

('Headlam' or the 'Company')

 

Transaction in Own Shares

 

Headlam (LSE: HEAD), Europe's leading floorcoverings distributor, announces that, in accordance with the terms of its share buyback programme announced on 9 March 2022 (the 'Share Buyback Programme'), the Company purchased the following number of its ordinary shares of 5 pence each ('Ordinary Shares') through Panmure Gordon (UK) Limited ("Panmure Gordon").

Date of purchase:

4 August 2022

Aggregate number of Ordinary Shares purchased:

4,853

Lowest price paid per share (GBp):

306.50

Highest price paid per share (GBp):

306.50

Volume weighted average price paid per share (GBp):

306.50

 

Headlam intends to retain the purchased shares in treasury, for later cancellation or reissue. Following the settlement of the above transaction(s), the remaining number of Ordinary Shares in issue will be 84,163,514 (excluding the 1,475,695 Ordinary Shares held in treasury). This number represents the total voting rights in the Company, and may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Panmure Gordon as part of the Share Buyback Programme.

Aggregate information: 

Venue

Volume-weighted average price (pence per share)

Aggregated volume

XLON

306.50

4,853

 

 Individual transactions:

Number of shares purchased

Transaction price(pence per share)

Time of transaction

Venue

4,853

306.50

08:25:16

XLON

 

Headlam Group plc

Tel: 01675 433 000

Chris Payne, Chief Executive

Catherine Miles, Director of IR and ESG

Email:  headlamgroup@headlam.com

Panmure Gordon (UK) Limited (Corporate Broker)

Tel: 020 7886 2500

Erik Anderson / Edward Walsh (Corporate Broking)

Atholl Tweedie / James Sinclair-Ford (Corporate Advisory)

 

Peel Hunt LLP (Corporate Broker)

Tel: 020 7418 8900

George Sellar / John Welch / Andrew Clark

Alma PR (Financial PR)

Tel: 020 3405 0205

Susie Hudson / David Ison / Lily Soares Smith

Email: headlam@almapr.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBKQBBABKDCFK
Date   Source Headline
9th Apr 20245:00 pmRNSEmployee Long Service Awards Scheme
21st Mar 20245:13 pmRNSDirector Declaration
18th Mar 20244:57 pmRNSGrant of awards under Deferred Bonus Plan & PSP
18th Mar 20244:53 pmRNSARA & Notice of AGM
7th Mar 20242:42 pmRNSDirector/PDMR Shareholding
5th Mar 20247:00 amRNSFinal Results
1st Mar 202410:01 amRNSHolding(s) in Company
28th Feb 20247:00 amRNSHolding(s) in Company
13th Feb 20242:17 pmRNSHolding(s) in Company
5th Feb 20249:40 amRNSNotice of Results
2nd Feb 202411:29 amRNSHolding(s) in Company
18th Jan 20247:00 amRNSPre-Close Update
12th Dec 20237:00 amRNSTrading Update
28th Nov 20239:31 amRNSDirector/PDMR Shareholding
9th Oct 202311:55 amRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSHolding(s) in Company
12th Sep 20234:27 pmRNSEmployee Long Service Awards Scheme
5th Sep 20237:00 amRNSHalf Year Results
14th Aug 20238:27 amRNSNotice of Results
1st Aug 20232:21 pmRNSDirector/PDMR Shareholding & Exercise of Option
27th Jul 20237:00 amRNSPre-Close Trading Update
21st Jul 20237:00 amRNSHolding(s) in Company
10th Jul 20238:47 amRNSHolding(s) in Company
10th Jul 20238:40 amRNSDirector Declaration
3rd Jul 202310:37 amRNSTotal Voting Rights
29th Jun 20235:14 pmRNSGrant of awards under the Company's PSP
29th Jun 20234:18 pmRNSExercise of options / Transfer of treasury shares
2nd Jun 20237:00 amRNSDirector/PDMR Shareholding
31st May 20239:56 amRNSHolding(s) in Company
31st May 20238:18 amRNSTotal Voting Rights
30th May 20239:56 amRNSDirector/PDMR Shareholding
26th May 20232:12 pmRNSHolding(s) in Company
25th May 202312:08 pmRNSResult of AGM
25th May 20237:00 amRNSAGM Trading Update
28th Apr 202311:01 amRNSTotal Voting Rights
24th Apr 20237:00 amRNSHolding(s) in Company
14th Apr 20234:16 pmRNSEmployee Long Service Awards Scheme
13th Apr 20234:33 pmRNSGrant of awards under Deferred Bonus Plan
31st Mar 20239:52 amRNSTotal Voting Rights
28th Mar 202311:53 amRNSDirector/PDMR Shareholding
20th Mar 20234:06 pmRNS2022 Annual Report and Notice of AGM
20th Mar 20237:00 amRNSChief Financial Officer Joins
14th Mar 20237:00 amRNSNew ‘Everyroom’ brand wins leading industry award
9th Mar 20239:00 amRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSFinal Results
3rd Mar 20237:10 amRNSCompletion of £15 million Share Buyback Programme
3rd Mar 20237:00 amRNSTransaction in Own Shares
2nd Mar 20237:00 amRNSTransaction in Own Shares
1st Mar 20233:02 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.